Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Contraception and Contraceptive Drugs

  Free Subscription


7 Contraception
2 Gynecol Endocrinol
2 Hum Reprod
1 J Clin Endocrinol Metab
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. MASTEN M, Larrea N, Schultz C, Lazorwitz A, et al
    Short-notice cancellations of laparoscopic permanent contraception.
    Contraception. 2022 May 8. pii: S0010-7824(22)00130.
    PubMed         Abstract available

  2. SOIN KS, Yeh PT, Gaffield ME, Ge C, et al
    Health workers' values and preferences regarding contraceptive methods globally: a systematic review.
    Contraception. 2022 May 5. pii: S0010-7824(22)00129.
    PubMed         Abstract available

  3. YEH PT, Kautsar H, Kennedy CE, Gaffield ME, et al
    Values and preferences for contraception: a global systematic review.
    Contraception. 2022 May 4. pii: S0010-7824(22)00128.
    PubMed         Abstract available

  4. FRIEDLANDER EB, Raidoo S, Soon R, Salcedo J, et al
    The experience of pain in real-time during medication abortion.
    Contraception. 2022;110:71-75.
    PubMed         Abstract available

  5. WHITEHOUSE KC, Shochet T, Lohr PA
    Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.
    Contraception. 2022;110:21-26.
    PubMed         Abstract available

  6. DUIJKERS IJM, Klipping C, Rautenberg T, Schug BS, et al
    Effect on ovarian activity and ovulation inhibition of different oral dosages of levonorgestrel.
    Contraception. 2022;110:6-15.
    PubMed         Abstract available

  7. CADDY C, Williams H, Hocking J, Coombe J, et al
    "I never went to see that doctor again": A qualitative study examining Australian women's experiences requesting removal of LARC within 12 months of insertion.
    Contraception. 2022;110:81-85.
    PubMed         Abstract available

    Gynecol Endocrinol

  8. LEPPANEN R, Tinkanen H, Huhtala H, Ahinko K, et al
    Single-administered GnRH agonist as luteal phase support in insemination cycles: a randomized controlled trial.
    Gynecol Endocrinol. 2022;38:438-442.
    PubMed         Abstract available

  9. KIZILKAYA Y, Ibanoglu MC, Kiykac Altinbas S, Engin-Ustun Y, et al
    A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms.
    Gynecol Endocrinol. 2022 Mar 23:1-4. doi: 10.1080/09513590.2022.2053956.
    PubMed         Abstract available

    Hum Reprod

  10. HAMEL CC, Vart P, Vandenbussche FPHA, Braat DDM, et al
    Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model.
    Hum Reprod. 2022 Mar 25. pii: 6554030. doi: 10.1093.
    PubMed         Abstract available

  11. MIDDELKOOP MA, de Lange ME, Clark TJ, Mol BWJ, et al
    Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
    Hum Reprod. 2022 Feb 10. pii: 6526433. doi: 10.1093.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  12. Correction to: BMI and Contraceptives Affect New Age-, Sex-, and Puberty-adjusted IGF-I and IGFBP-3 Reference Ranges Across Life Span.
    J Clin Endocrinol Metab. 2022 May 10. pii: 6583336. doi: 10.1210.


  13. AVERBACH S, Hofler L
    Long-Acting Reversible Contraception With Contraceptive Implants and Intrauterine Devices.
    JAMA. 2022 May 6. pii: 2792212. doi: 10.1001/jama.2022.5448.

    PLoS One

  14. WORKU MG, Alamneh TS, Teshale AB, Yeshaw Y, et al
    Multilevel analysis of determinants of anemia among young women (15-24) in sub-Sahara Africa.
    PLoS One. 2022;17:e0268129.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.